PROCLEIX® ULTRIO® Assay

* FDA approved to screen donors for HIV-1 and HCV only.

First 3-in-1 Nucleic Acid Test

  • Designed with TMA technology to simultaneously test HIV-1, HCV, and HBV in a single tube*
  • Produces one result for three markers in the same time as the PROCLEIX® HIV-1/HCV Assay, without adding staff or instrumentation Optimized Efficiency
  • Up to 696 results in pools of 8, or 87 individual donor test results per operator
  • Fast turnaround: results in 5-6 hours

Maximized Utility

The PROCLEIX® ULTRIO® Assay tests:

  • Plasma and serum specimens from donors of whole blood and blood components, and from other living donors
  • Plasma and serum specimens from organ donors
  • Blood specimens from cadaveric donors

See Intended Use for details.

Ease of Use

  • Single-tube process minimizes material transfer steps; potential for contamination
  • Color change confirms addition of each reagent
  • Bar-coded sample tracking provides positive sample identity

Minimal impact on current operation

  • Uses familiar PROCLEIX® instrumentation
  • Modular PROCLEIX® System for low- to mid-volume testing
  • Typically requires no changes in lab configuration, staffing or equipment
  • Similar to established protocols
Developed by Gen-Probe in collaboration with Chiron. Manufactured by Gen-Probe Incorporated. Distributed by Novartis Vaccines and Diagnostics, Inc.